Most people simply take ibuprofen when they get a headache. But for someone with hydrocephalus – a potentially life-threatening condition in which excess fluid builds up in the brain — a headache can indicate a serious problem that can result in a hospital visit, thousands of dollars in scans, radiation and sometimes surgery.
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus and potentially save the U.S. health care system millions of dollars.
A Northwestern Medicine clinical study successfully tested the device, known as a wearable shunt monitor, on five adult patients with hydrocephalus. The findings were published in Science Translational Medicine.
Hydrocephalus can affect adults and children. Often the child is born with the condition, whereas in adults, it can be acquired from some trauma-related injury, such as bleeding inside the brain or a brain tumor.
The current standard of care involves the surgical implantation of a straw-like catheter known as a ‘shunt,’ which drains the excess fluid out of the brain and into another part of the body.
Shunts have a nearly 100 percent failure rate over 10 years, and diagnosing shunt failure is notoriously difficult. More than a million Americans live with shunts and the constant threat of failure.
The groundbreaking new sensor, developed by the Rogers Research Group at Northwestern, could create immense savings and improve the quality of life for nearly a million people in the U.S. alone.
- 1 in 1,000 people affected by hydrocephalus
- 100% failure rate of shunts over 10 years
- $50,000 treatment costs per patient per year
When a shunt fails, the patient can experience headaches, nausea and low energy. A patient experiencing any of these symptoms must visit a hospital because if their symptoms are caused by a malfunctioning shunt, it could be life threatening. Once at the hospital, the patient must get a CT scan or an MRI and sometimes must undergo surgery to see if the shunt is working properly.
The new sensor allowed patients in the study to determine within five minutes of placing it on their skin if fluid was flowing through their shunt. The soft and flexible sensor uses measurements of temperature and heat transfer to non-invasively tell if and how much fluid is flowing through.
“We envision you could do this while you’re sitting in the waiting room waiting to see the doctor,” said co-lead author Siddharth Krishnan, a fifth-year Ph.D. student in the Rogers Research Group. “A nurse could come and place it on you and five minutes later, you have a measurement.”
I’m trying to live a normal life, and I really can’t because of the headaches.”
A device like this would be life changing for Willie Meyer, 26, who has undergone 190 surgeries, spent virtually every holiday in the emergency room and almost missed his high school graduation because of emergency brain surgeries.
Meyer’s mother, Beth, said she learned Willie had hydrocephalus when he was two years old after complaining that “his hair hurt.”
Symptoms of a malfunctioning shunt, such as headaches and fatigue, are similar to symptoms of other illnesses, which causes confusion and stress for caregivers.
“Every time your kid says they have a headache or feels a little sleepy, you automatically think, ‘Is this the shunt?’” said co-senior author Dr. Matthew Potts, assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We believe that this device can spare patients a lot of the danger and costs of this process.”
Co-lead author Dr. Amit Ayer, who has treated Willie’s hydrocephalus for the last four years, said his patients are a driving force behind his motivation to get the device to market.
“Our patients want to know when they can actually use the device and be part of the trial,” said Ayer, who is a neurosurgery resident at Northwestern Medicine and a student at Kellogg School of Management at Northwestern. “I want to get it out there, so we can help make their lives better.”
How it works
It looks like a Band-Aid that’s talking to a cellphone. There’s nothing like this out there today.”
John A. Rogers
A very small rechargeable battery is built into the sensor. The device is Bluetooth enabled so it can talk to a smartphone and deliver the readings via an Android app. The sensor advances concepts in skin-like “epidermal electronics,” which the Rogers Research Group has been working on for nearly a decade.
It uses a thermal transport measurement, which means the sensor uses tiny amounts of thermal power to minimally increase the temperature of the skin.
If the shunt is working and the excess cerebral spinal fluid is draining properly, the sensor will measure a characteristic heat signature. Similarly, if there is no flow because the shunt has malfunctioned, the sensor will be able to quickly indicate that through heat flow measurements.
The team tested the device in the laboratory before heading to the clinic to perform a pilot study on five patients at Northwestern Memorial Hospital. The team could detect clear differences in cases between measurements over working shunts and on adjacent confusing control locations with no flow.
“This means if someone wants to check if their shunt is working, say, when they have a headache, they can quickly do what we call a ‘spot measurement,’” said co-lead author Tyler Ray, a postdoctoral research fellow in the Rogers Research Group. “This device can also measure flow throughout the day enabling, for the first time, the possibility of continuously monitoring shunt performance. This can lead to important insights into the dynamics of cerebral spinal fluid flow previously inaccessible with current diagnostic tools and flow measurement techniques.”
A larger pediatric clinical trial will be starting soon at Ann & Robert H. Lurie Children’s Hospital of Chicago with the goal of targeting this very vulnerable population. The study authors are also working on outsourced production on the scale of a few hundred sensors to support this study and further develop the technology. Rogers and Ayer are co-founders of Rhaeos, Inc., a company that is commercializing the technology described here.
The Latest on: Hydrocephalus
via Google News
The Latest on: Hydrocephalus
- Three-year-old Peterborough girl battling rare brain diseaseon August 15, 2019 at 11:56 am
Waawaate Ma'iingan, 3, has hydrocephalus, a buildup of fluid in ventricles of the brain that puts pressure on the brain. Before she was six months old, she had nine brain surgeries. The condition has ...
- Global Hydrocephalus Shunts Market 2019 – Medtronic, Johnson and Johnson, Integra LifeSciences, SOPHYSA, B.BRAUNon August 13, 2019 at 9:30 pm
Aug 14, 2019 (Eon Market Research via COMTEX) -- The Global Hydrocephalus Shunts Market 2019 Industry Trends and Forecasts to 2026 is a professional and in-depth study on the current state of the ...
- Can You Help? Western New York Walk to End Hydrocephaluson August 10, 2019 at 4:06 am
Before the age of 1, Becky Goldberg Petty’s son, Simon (pictured), already had two brain surgeries to treat a condition called hydrocephalus, and there is a chance he could need another surgery at any ...
- After 30 surgeries, this Queens resident rides with a purpose: helping children suffering from chronic diseaseson August 9, 2019 at 10:45 am
Yehuda Gelman, 34, was born with hydrocephalus, a rare disease in which spinal fluid accumulates in his brain, requiring more than 30 surgeries to treat. He’s valiantly battled the disease while ...
- Parents of an 11-month-old girl with a balloon-like growth on her head are desperately trying to find a surgeon who can remove the bizarre masson August 8, 2019 at 9:03 pm
Miss Chavoso, 18, and MK's father, Reynaldo Cruz, 32, believe their daughter has a condition called hydrocephalus. This is a disorder in which spinal fluid builds up within the brain, putting pressure ...
- The expression of cerebrospinal fluid exosomal miR-630 plays an important role in the dysfunction of endothelial cells after subarachnoid hemorrhageon August 8, 2019 at 2:19 am
We further compared the exosomal miR-630 of clinical patients between aSAH and normal hydrocephalus. The adhesion molecules expression was further detected after co-incubation with exosomes ...
- Rohingya child with hydrocephalus treated in Dhakaon August 8, 2019 at 12:02 am
He was given special permission by camp authorities to seek treatment in Dhaka A Rohingya refugee child, with a health condition called hydrocephalus, has undergone a potentially life-saving procedure ...
- Cars for a Cure; raising awareness for hydrocephaluson August 4, 2019 at 2:35 pm
MARSHALL - A collection of old and new cars and motorcycles were used to raise awareness for hydrocephalus Saturday at the first annual Car Show for a Cure. The event featured 55 different types of ...
- Hydrocephalus Market Size Is Estimated To Reach USD 1,752.07 Million By 2023on July 31, 2019 at 9:09 am
The global Hydrocephalus Market Size is estimated to balloon to USD 1,752.07 million by 2023, asserts Market Research Future (MRFR). It can exhibit 4.4% CAGR over the forecast period (2018-2023).
via Bing News